Clinical Trial Update: Apatinib for Esophageal Squamous Cell Cancer After the Failure of Standard Treatment [Phase 2]

View source ↗

Summary

Phase 2 trial updating apatinib for esophageal squamous cell carcinoma after standard-treatment failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Yuhong Li | Conditions: Esophageal Squamous Cell Carcinoma | Phase 2 | Status: COMPLETED